Chronic myelogenous leukemia, BCR/ABL positive

Clinical trials for Chronic myelogenous leukemia, BCR/ABL positive explained in plain language.

Never miss a new study

Get alerted when new Chronic myelogenous leukemia, BCR/ABL positive trials appear

Sign up with your email to follow new studies for Chronic myelogenous leukemia, BCR/ABL positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Personalized dasatinib dosing aims to tame leukemia with fewer side effects

Disease control Completed

This study tests whether adjusting the daily dose of the leukemia drug dasatinib based on a patient's blood levels can improve safety and effectiveness. Adults newly diagnosed with chronic phase chronic myeloid leukemia (CML) will receive either standard dosing or a dose tailored…

Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA, BCR/ABL POSITIVE

Phase 2 • Sponsor: Versailles Hospital • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Chronic myelogenous leukemia, BCR/ABL positive

Get alerted when new Chronic myelogenous leukemia, BCR/ABL positive trials appear

Personalized dasatinib dosing aims to tame leukemia with fewer side effects